Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne E Lapi

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Molecular Imaging and Biology|May 6, 2016
[<sup>89</sup>Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast CancerRichard Laforest, Suzanne E Lapi, Reiko Oyama, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 2, 2026
Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry-An FNIH Joint Academic, Clinical, and Industrial CollaborationDale L Bailey, John C Dickson, Suzanne E Lapi, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 23, 2021
A heavy-ion production channel of <sup>149</sup>Tb via <sup>63</sup>Cu bombardment of <sup>89</sup>YJohn T Wilkinson, Kendall E Barrett, Samuel J Ferran, et al.
Theranostics|August 15, 2019
Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-OncologyBenjamin B Kasten, Neha Udayakumar, Jianmei W Leavenworth, et al.
ACS Omega|March 3, 2025
[<sup>45</sup>Ti]Ti-HOPOs: Potential Complexes for the Development of <sup>45</sup>Ti PET Imaging AgentsShefali Saini, N V S Dinesh K Bhupathiraju, Samith B Jayawardana, et al.
Oncotarget|December 22, 2017
Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agentBernadette V Marquez-Nostra, Supum Lee, Richard Laforest, et al.
Chemical Reviews|October 28, 2025
Chemical Tools to Characterize the Coordination Chemistry of Radionuclides for Radiopharmaceutical ApplicationsEszter Boros, Peter Comba, Jonathan W Engle, et al.
Nature|January 9, 2019
The surprisingly large neutron capture cross-section of <sup>88</sup>ZrJennifer A Shusterman, Nicholas D Scielzo, Keenan J Thomas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Quantitative [<sup>89</sup>Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRIAmeer Mansur, Jonathan E McConathy, Erica Stringer-Reasor, et al.
Nuclear Medicine and Biology|March 9, 2026
Spatial resolution and image quality of radionuclides for PET imagingSharon L Samuel, Solana Fernandez, Shelbie J Cingoranelli, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Molecular Imaging and Biology|May 6, 2016
[<sup>89</sup>Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast CancerRichard Laforest, Suzanne E Lapi, Reiko Oyama, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 2, 2026
Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry-An FNIH Joint Academic, Clinical, and Industrial CollaborationDale L Bailey, John C Dickson, Suzanne E Lapi, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 23, 2021
A heavy-ion production channel of <sup>149</sup>Tb via <sup>63</sup>Cu bombardment of <sup>89</sup>YJohn T Wilkinson, Kendall E Barrett, Samuel J Ferran, et al.
Theranostics|August 15, 2019
Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-OncologyBenjamin B Kasten, Neha Udayakumar, Jianmei W Leavenworth, et al.
ACS Omega|March 3, 2025
[<sup>45</sup>Ti]Ti-HOPOs: Potential Complexes for the Development of <sup>45</sup>Ti PET Imaging AgentsShefali Saini, N V S Dinesh K Bhupathiraju, Samith B Jayawardana, et al.
Oncotarget|December 22, 2017
Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agentBernadette V Marquez-Nostra, Supum Lee, Richard Laforest, et al.
Chemical Reviews|October 28, 2025
Chemical Tools to Characterize the Coordination Chemistry of Radionuclides for Radiopharmaceutical ApplicationsEszter Boros, Peter Comba, Jonathan W Engle, et al.
Nature|January 9, 2019
The surprisingly large neutron capture cross-section of <sup>88</sup>ZrJennifer A Shusterman, Nicholas D Scielzo, Keenan J Thomas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Quantitative [<sup>89</sup>Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRIAmeer Mansur, Jonathan E McConathy, Erica Stringer-Reasor, et al.
Nuclear Medicine and Biology|March 9, 2026
Spatial resolution and image quality of radionuclides for PET imagingSharon L Samuel, Solana Fernandez, Shelbie J Cingoranelli, et al.
Pageof 18